Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cavallaro

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1993
Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistenceR Cavallaro, M G Regazzetti, E Mundo, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 5, 2011
Factors involved in the level of functioning of patients with schizophrenia according to latent variable modelingP-M Llorca, O Blanc, L Samalin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Reduced haloperidol/haloperidol ratio and clinical outcome in schizophrenia: preliminary evidencesC Altamura, M Mauri, R Cavallaro, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 13, 2010
Management of physical health in patients with schizophrenia: international insightsI B Chaudhry, J Jordan, F-R Cousin, et al.
Neurochemical Research|June 1, 1995
Olfactory transduction mechanisms in sheepE Fabbri, M E Ferretti, M Buzzi, et al.
CNS Drugs|April 20, 2004
Citalopram concentrations and response in obsessive-compulsive disorder. Preliminary resultsSilvio R Bareggi, L Bianchi, R Cavallaro, et al.
Clinical Neuropharmacology|January 1, 1990
Factors affecting the clinical response to haloperidol therapy in schizophreniaS R Bareggi, M Mauri, R Cavallaro, et al.
Schizophrenia Research|October 13, 2009
'Theory' of mind impairment in patients affected by schizophrenia and in their parentsS Anselmetti, M Bechi, M Bosia, et al.
Neuropsychological Rehabilitation|July 28, 2010
Computer-aided neurocognitive remediation in schizophrenia: durability of rehabilitation outcomes in a follow-up studySara Poletti, S Anselmetti, M Bechi, et al.
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|November 1, 1992
Adenylate cyclase from Hirudo medicinalis segmental ganglia: modulation by physiological and non-physiological agentsM E Ferretti, M C Pareschi, A L Campi, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1993
Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistenceR Cavallaro, M G Regazzetti, E Mundo, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 5, 2011
Factors involved in the level of functioning of patients with schizophrenia according to latent variable modelingP-M Llorca, O Blanc, L Samalin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Reduced haloperidol/haloperidol ratio and clinical outcome in schizophrenia: preliminary evidencesC Altamura, M Mauri, R Cavallaro, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 13, 2010
Management of physical health in patients with schizophrenia: international insightsI B Chaudhry, J Jordan, F-R Cousin, et al.
Neurochemical Research|June 1, 1995
Olfactory transduction mechanisms in sheepE Fabbri, M E Ferretti, M Buzzi, et al.
CNS Drugs|April 20, 2004
Citalopram concentrations and response in obsessive-compulsive disorder. Preliminary resultsSilvio R Bareggi, L Bianchi, R Cavallaro, et al.
Clinical Neuropharmacology|January 1, 1990
Factors affecting the clinical response to haloperidol therapy in schizophreniaS R Bareggi, M Mauri, R Cavallaro, et al.
Schizophrenia Research|October 13, 2009
'Theory' of mind impairment in patients affected by schizophrenia and in their parentsS Anselmetti, M Bechi, M Bosia, et al.
Neuropsychological Rehabilitation|July 28, 2010
Computer-aided neurocognitive remediation in schizophrenia: durability of rehabilitation outcomes in a follow-up studySara Poletti, S Anselmetti, M Bechi, et al.
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|November 1, 1992
Adenylate cyclase from Hirudo medicinalis segmental ganglia: modulation by physiological and non-physiological agentsM E Ferretti, M C Pareschi, A L Campi, et al.
Pageof 4